These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16995869)

  • 21. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
    Patel CG; Harmon M; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
    Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
    Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
    McCrea JB; Macha S; Adedoyin A; Marshall W; Menzel K; Cho CR; Liu F; Zhao T; Levine V; Kraft WK; Yoon E; Panebianco D; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2019 Oct; 59(10):1331-1339. PubMed ID: 30990905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil pharmacokinetics in transplant patients receiving cyclosporine or tacrolimus in combination therapy.
    Vidal E; Cantarell C; Capdevila L; Monforte V; Roman A; Pou L
    Pharmacol Toxicol; 2000 Oct; 87(4):182-4. PubMed ID: 11097273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine and sirolimus interaction in a kidney transplant patient.
    Dabrowska-Zamojcin E; Pawlik A; Domański L; Rózański J; Droździk M
    Transplant Proc; 2005 Jun; 37(5):2317-9. PubMed ID: 15964407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of mycophenolate mofetil and sirolimus in children.
    Filler G; Bendrick-Peart J; Christians U
    Ther Drug Monit; 2008 Apr; 30(2):138-42. PubMed ID: 18367972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of mycophenolate mofetil and intravenous ganciclovir alone and in combination in renal transplant recipients.
    Wolfe EJ; Mathur V; Tomlanovich S; Jung D; Wong R; Griffy K; Aweeka FT
    Pharmacotherapy; 1997; 17(3):591-8. PubMed ID: 9165564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant.
    Meaney CJ; Sudchada P; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
    J Clin Pharmacol; 2019 Oct; 59(10):1351-1365. PubMed ID: 31062373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.
    Cattaneo D; Cortinovis M; Baldelli S; Bitto A; Gotti E; Remuzzi G; Perico N
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1147-55. PubMed ID: 17928466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
    Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
    Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period.
    Kiberd BA; Puthenparumpil JJ; Fraser A; Tett SE; Lawen J
    Transplant Proc; 2005 Jun; 37(5):2320-3. PubMed ID: 15964408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.
    Rogers CC; Alloway RR; Alexander JW; Cardi M; Trofe J; Vinks AA
    Clin Transplant; 2008; 22(3):281-91. PubMed ID: 18482049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.
    Naesens M; de Loor H; Vanrenterghem Y; Kuypers DR
    Transplantation; 2007 Aug; 84(3):362-73. PubMed ID: 17700162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil.
    Kamar N; Van TT; Ribes D; Modesto A; Cointault O; Lavayssière L; Ader JL; Durand D; Rostaing L
    Exp Clin Transplant; 2006 Dec; 4(2):532-6. PubMed ID: 17238854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
    Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
    Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
    Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.